389 related articles for article (PubMed ID: 9675107)
21. Inhibition of human brain and RBC acetylcholinesterase (AChE) by heptylphysostigmine (HPTL).
Moriearty PL; Becker RE
Methods Find Exp Clin Pharmacol; 1992 Oct; 14(8):615-21. PubMed ID: 1494302
[TBL] [Abstract][Full Text] [Related]
22. Computational and Kinetic Studies of Acetylcholine Esterase Inhibition by Phenserine.
Tabrez S; Damanhouri GA
Curr Pharm Des; 2019; 25(18):2108-2112. PubMed ID: 31258059
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of the inhibition of acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom by local anesthetics: procaine and tetracaine.
al-Jafari AA; Kamal MA; Duhaiman AS; Alhomida AS
J Enzyme Inhib; 1996 Oct; 11(2):123-34. PubMed ID: 9204401
[TBL] [Abstract][Full Text] [Related]
24. Kinetic analysis of the toxicological effect of tacrine (Cognex) on human retinal acetylcholinesterase activity.
Alhomida AS; Al-Rajhi AA; Kamal MA; Al-Jafari AA
Toxicology; 2000 May; 147(1):33-9. PubMed ID: 10837930
[TBL] [Abstract][Full Text] [Related]
25. Ambenonium is a rapidly reversible noncovalent inhibitor of acetylcholinesterase, with one of the highest known affinities.
Hodge AS; Humphrey DR; Rosenberry TL
Mol Pharmacol; 1992 May; 41(5):937-42. PubMed ID: 1588924
[TBL] [Abstract][Full Text] [Related]
26. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human plasma cholinesterase and erythrocyte acetylcholinesterase by nondepolarizing neuromuscular blocking agents.
Kato M; Hashimoto Y; Horinouchi T; Ando T; Ito J; Yamanaka H
J Anesth; 2000 Jan; 14(1):30-4. PubMed ID: 14564607
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of the inhibition of acetylcholinesterase in camel retina by cisplatin.
Al-Jafari AA; Al-Khwyter F; Kamal MA
Cancer Lett; 1998 Jun; 128(1):79-86. PubMed ID: 9652796
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile.
Pietsch M; Christian L; Inhester T; Petzold S; Gütschow M
FEBS J; 2009 Apr; 276(8):2292-307. PubMed ID: 19292865
[TBL] [Abstract][Full Text] [Related]
31. Isolation and cholinesterase-inhibition studies of sterols from Haloxylon recurvum.
Ahmed E; Nawaz SA; Malik A; Choudhary MI
Bioorg Med Chem Lett; 2006 Feb; 16(3):573-80. PubMed ID: 16274989
[TBL] [Abstract][Full Text] [Related]
32. Kinetic evidence for the allosteric substrate inhibition of human erythrocyte acetylcholinesterase.
Niday E; Wang CS; Alaupovic P
Biochim Biophys Acta; 1980 Mar; 612(1):67-72. PubMed ID: 7362833
[TBL] [Abstract][Full Text] [Related]
33. Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.
Yu QS; Pei XF; Holloway HW; Greig NH; Brossi A
J Med Chem; 1997 Aug; 40(18):2895-901. PubMed ID: 9288171
[TBL] [Abstract][Full Text] [Related]
34. Mipafox differential inhibition assay for heart muscle cholinesterases: substrate specificity and inhibition of three isoenzymes by physostigmine and quinidine.
Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
Gen Pharmacol; 1997 Apr; 28(4):567-75. PubMed ID: 9147026
[TBL] [Abstract][Full Text] [Related]
35. Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze.
Iijima S; Greig NH; Garofalo P; Spangler EL; Heller B; Brossi A; Ingram DK
Psychopharmacology (Berl); 1993; 112(4):415-20. PubMed ID: 7871051
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of human erythrocyte acetylcholinesterase by succinyldicholine.
Lanks KW; Sklar GS
Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):269-75. PubMed ID: 940960
[TBL] [Abstract][Full Text] [Related]
37. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
[TBL] [Abstract][Full Text] [Related]
38. [Synthetic bioantioxidants--inhibitors of acetylcholinesterase activity].
Braginskaia FI; Zorina OM; Molochkina EM; Nikiforov GA; Burlakova EB
Izv Akad Nauk SSSR Biol; 1992; (5):690-8. PubMed ID: 1447418
[TBL] [Abstract][Full Text] [Related]
39. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
Yu Q; Greig NH; Holloway HW; Brossi A
J Med Chem; 1998 Jun; 41(13):2371-9. PubMed ID: 9632370
[TBL] [Abstract][Full Text] [Related]
40. The inhibitory effect of the neuromuscular blocking agent, gallamine triethiodide, on camel retina acetylcholinesterase activity.
Al-Jafari AA
Toxicol Lett; 1997 Jan; 90(1):45-51. PubMed ID: 9020401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
